Practical implications of differential discounting of costs and health effects in cost-effectiveness analysis

Value in Health

Volumn 14, Issue 8, 2011, Pages 1174-1175

  O'Mahony, James ^a,b   De Kok, Inge ^a   Van Rosmalen, Joost ^a   Habbema, J Dik F ^a   Brouwer, Werner ^a   Van Ballegooijen, Marjolein ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

BELGIUM; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH ECONOMICS; HERD IMMUNITY; HUMAN; LETTER; NATIONAL HEALTH ORGANIZATION; NETHERLANDS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VACCINATION;

EID: 82955239859     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.09.001     Document Type: Letter

References (2)

1. NICE Discounting health benefits in special circumstances http://www.nice.org.uk/media/955/4F/Clarification-to-section-5. 6-of-the-Guide-to-Methods-of-Technology-Appraisals.pdf [Accessed August 25, 2011]
2. D. Koleva, P. De Compadri, A. Padula Economic evaluation of human papillomavirus vaccination in the European Union: a critical review Intern Emerg Med 6 2011 163 174